Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-029879

EVP, Research & CSO sold 3,805 shares at $30.07 ($114,418)

  • EVP, Research & CSO acquired 3,805 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Virgin Herbert · EVP, Research & CSO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2020-05-14 Exercise or conversion : show line 1 in the form +3,805 $1.53 $5,822 3,805 D
2020-05-14 Sale : show line 2 in the form −3,805 $30.07 $114,418 0 D
Open-market sales · 3,805 sh · avg $30.07 · $114,418

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-05-14 Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) −3,805 551,750 D
Loading xslF345X03/doc4.xml…